Benzimidazole drugs and modulation of biotransformation enzymes

被引:194
作者
Velík, J
Baliharová, V
Fink-Gremmels, J
Bull, S
Lamka, J
Skálová, L
机构
[1] Charles Univ Prague, Fac Pharm, Res Ctr LN00B125, Dept Pharmacol & Toxicol, CZ-50005 Hradec Kralove, Czech Republic
[2] Charles Univ Prague, Fac Pharm, Res Ctr LN00B125, Dept Biochem Sci, CZ-50005 Hradec Kralove, Czech Republic
[3] Univ Utrecht, Div Vet Pharm Pharm & Toxicol, Utrecht, Netherlands
关键词
benzimidazole; cytochrome P450; enzyme induction; enzyme inhibition; anthelmintic; proton pump inhibitors;
D O I
10.1016/j.rvsc.2003.08.005
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Benzimidazole drugs (e.g., anthelmintics albendazole, fenbendazole, oxfenbendazole, thiabendazole, mebendazole; inhibitors of proton pump omeprazole, lansoprasole, pantoprasole) represent substances used in both human and veterinary medicine; however, from the point of view of induction and inhibition of biotransformation enzymes, research has been carried out mainly due to the initiative of human pharmacologists. The purpose of the present review is to inform about inductive and inhibitive effects of benzimidazole drugs in man, animals and cell cultures. Pharmacological and toxicological consequences of modulation of biotransformation enzymes are discussed and the significance of studies in the field of modulation of biotransformation enzymes in food-producing animals is explained. Since the modulating effect of benzimidazoles strongly varies depending on structure of the individual substances, the particular attention is paid to structure-modulation relationships. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:95 / 108
页数:14
相关论文
共 116 条
[1]   THIABENDAZOLE IS AN INDUCER OF CYTOCHROME P4501A1 IN CULTURED RABBIT HEPATOCYTES [J].
AIX, L ;
REYGROBELLET, X ;
LARRIEU, G ;
LESCA, P ;
GALTIER, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (03) :1483-1489
[2]  
AMRI HS, 1988, J PHARMACOL EXP THER, V246, P758
[3]  
[Anonymous], [No title captured]
[4]   Induction of cytochrome P450 enzymes by albendazole treatment in the rat [J].
Asteinza, J ;
Camacho-Carranza, R ;
Reyes-Reyes, RE ;
Dorado-González, V ;
Espinosa-Aguirre, JJ .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2000, 9 (1-2) :31-37
[5]   Structural and mechanistic aspects of transcriptional induction of cytochrome P450 1A1 by benzimidazole derivatives in rat hepatoma H4IIE cells [J].
Backlund, M ;
Weidolf, L ;
Ingelman-Sundberg, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 261 (01) :66-71
[6]   THE ABSORPTION, DISTRIBUTION AND ELIMINATION OF ANTHELMINTIC DRUGS - THE ROLE OF PHARMACOKINETICS [J].
BAGGOT, JD ;
MCKELLAR, QA .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1994, 17 (06) :409-419
[7]   The effects of benzimidazole anthelmintics on P4501A in rat hepatocytes and HepG2 cells [J].
Baliharová, V ;
Skálová, L ;
Maas, RFM ;
De Vrieze, G ;
Bull, S ;
Fink-Gremmels, J .
RESEARCH IN VETERINARY SCIENCE, 2003, 75 (01) :61-69
[8]   The effects of mebendazole on P4501A activity in rat hepatocytes and HepG2 cells.: Comparison with tiabendazole and omeprazole [J].
Baliharová, V ;
Skálová, L ;
Maas, RFM ;
De Vrieze, G ;
Bull, S ;
Fink-Gremmels, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (06) :773-781
[9]   Cytochrome P450 1A1/2 induction by antiparasitic drugs:: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells [J].
Bapiro, TE ;
Andersson, TB ;
Otter, C ;
Hasler, JA ;
Masimirembwa, CM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (08) :537-542
[10]   ENZYME-INDUCTION AND INHIBITION [J].
BARRY, M ;
FEELY, J .
PHARMACOLOGY & THERAPEUTICS, 1990, 48 (01) :71-94